BMJ Open Respiratory Research (Aug 2021)

Objective measurement of lung volume recruitment therapy: laboratory and clinical validation

  • David J Berlowitz,
  • Mark E Howard,
  • Sherri L Katz,
  • Nicole Sheers,
  • Douglas A McKim,
  • Phoebe E Naughton

DOI
https://doi.org/10.1136/bmjresp-2021-000918
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

Results Minimum counter activation pressure under conditions of zero leak was 1.9±0.4 cm H2O. No difference was observed between the number of repetitions delivered and recorded during high airway pressure condition. Interface leak approximating 25% resulted in underestimation of repetition counts, and once the leak was at 50% or beyond, the counter recorded no activity. Faster sampling frequency collected data with more fidelity. Counter data agreed with diary self-report during community trials (16 participants, 960 participant days, 77% agreement, Cohen’s Κ=0.66 and p<0.001). Disagreement typically favoured more diary reported (18%) than counter (5%) sessions.Conclusions The performance characteristics of a new lung volume recruitment counter have been established in both laboratory and community settings. Objective usage and dosage data should accelerate new knowledge development and better translation of lung volume recruitment therapy into policy and practice.